Reading through the
interim report of the Cass review of treatment for children and adolescents with gender dysphoria at the moment.
Some points that stand out in relation to the evidence base.
"1.23. Evidence on the appropriate management of children and young people with gender incongruence and dysphoria is inconclusive both nationally and internationally."
This contrasts with the certainty expressed by activist lobby groups and activist clinicians.
"1.24. A lack of a conceptual agreement about the meaning of gender dysphoria hampers research, as well as NHS clinical service provision."
Gender dysphoria is a poorly understood and contested condition, as many of us have been saying.
"1.27. There has been research on the short-term mental health outcomes and physical side effects of puberty blockers for this cohort, but very limited research on the sexual, cognitive or broader developmental outcomes."
This contrasts with the frequent claim that puberty blockers have been found to be safe and reversible.
"1.29. Aspects of the literature are open to interpretation in multiple ways, and there is a risk that some authors interpret their data from a particular ideological and/or theoretical standpoint"
Who would have thought?
It looks as though GIDS Tavistock may end up winding down and treatment being distributed to local centres.